Home › Asset managers › Compare 2024-2025 › Charles Schwab vs John Hancock
Charles Schwab 2024-2025 · John Hancock 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 8,674 | 7,532 | 466 | 676 | 94.2% | 91.7% |
| Board proposals | 7,415 | 6,620 | 379 | 416 | 94.6% | 92.9% |
| E&S shareholder proposals | 252 | 126 | 13 | 113 | 90.6% | 81.3% |
| Other items | 1,007 | 786 | 74 | 147 | 91.4% | 85.1% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
795 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Charles Schwab | John Hancock |
|---|---|---|---|---|---|---|
| CLARIVATE PLC | May 7, 2025 | APPROVAL OF THE CLARIVATE PLC AMENDED AND RESTATED 2019 INCENTIVE AWARD PLAN. Compensation |
Board | For | FOR 11 funds |
AGAINST 4 funds |
| CLARUS CORP. | May 29, 2025 | To consider and vote on a proposal to amend and restate the Company's 2015 Stock Incentive Plan to, among other things, extend the term of such plan by 10 years and reserve 7,500,000 shares of the Company's common stock for issuance under such plan. Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| COCA-COLA CONSOLIDATED INC. | May 13, 2025 | Approval of the amendment to Coca-Cola Consolidated's Restated Certificate of Incorporation to effect a 10-for-1 forward stock split of Coca-Cola Consolidated Common Stock and Class B Common Stock and to proportionately increase the number of authorized shares of Coca-Cola Consolidated Common Stock and Class B Common Stock. Capital Structure |
Board | For | AGAINST 13 funds |
FOR 6 funds |
| CODEXIS INC. | June 10, 2025 | To approve an amendment to the Codexis, Inc. 2019 Incentive Award Plan to increase the number of shares available for issuance thereunder by 8,000,000 shares. Compensation |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| CODEXIS INC. | June 10, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 5 funds |
| COLLEGIUM PHARMACEUTICAL INC. | May 15, 2025 | To approve the Collegium Pharmaceutical, Inc. 2025 Equity Incentive Plan Compensation |
Board | For | FOR 8 funds |
AGAINST 3 funds |
| COMPASS INC. | May 22, 2025 | Election of Class I Director: Dawanna Williams Director Elections |
Board | For | FOR 9 funds |
AGAINST 3 funds |
| COMPASS INC. | May 22, 2025 | Election of Class I Director: Robert Reffkin Director Elections |
Board | For | FOR 9 funds |
AGAINST 3 funds |
| COMPX INTERNATIONAL INC. | May 21, 2025 | Say-on-Pay, nonbinding advisory vote approving executive compensation. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| CONTANGO ORE INC. | June 10, 2025 | To conduct a non-binding, advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 4 funds |
| CRISPR THERAPEUTICS AG | June 5, 2025 | Binding vote on maximum equity for members of the Board of Directors from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders. Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | Binding vote on maximum equity for members of the Executive Committee from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders. Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | Re-election of H. Edward Fleming, Jr., M.D. Director Elections |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | Re-election of John T. Greene Director Elections |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| CRONOS GROUP INC | July 19, 2024 | ADOPTION OF AN ADVISORY (NON-BINDING) RESOLUTION TO APPROVE THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT DATED APRIL 26, 2024 Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| CSP INC. | February 4, 2025 | Approve and adopt the CSP INC. 2025 Stock Incentive Plan. Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CUTERA INC. | July 15, 2024 | Approval of the amendment and restatement of our 2019 Equity Incentive Plan to increase the total shares available for issuance under the 2019 Equity Incentive Plan by 2,395,275 shares. Compensation |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| CUTERA INC. | July 15, 2024 | Non-binding advisory vote on the compensation of Named Executive Officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| CVR ENERGY INC. | June 5, 2025 | To approve the Third Amended & Restated CVR Energy, Inc. 2007 Long-Term Incentive Plan. Compensation |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| CVR ENERGY INC. | June 5, 2025 | To approve, on an advisory basis, our named executive officer compensation. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 6 funds |
| DANIMER SCIENTIFIC INC. | July 9, 2024 | Approval of an amendment to the Company's 2020 Long-Term Incentive Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| DAVE & BUSTER'S ENTERTAINMENT INC. | June 18, 2025 | Approval of 2025 Omnibus Incentive Plan Compensation |
Board | For | FOR 7 funds |
AGAINST 3 funds |
| DEFINITIVE HEALTHCARE CORP. | June 5, 2025 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 6 funds |
| DELCATH SYSTEMS INC. | May 15, 2025 | To approve an amendment of the Company's 2020 Omnibus Equity Incentive Plan to increase by 2,200,000 the number of shares of common stock, $0.01 par value per share ("Common Stock") available thereunder. Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| DIANTHUS THERAPEUTICS INC. | May 22, 2025 | To approve, on an advisory basis, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 3 funds |
| DIGI INTERNATIONAL INC. | February 3, 2025 | Company proposal to approve the amendment and restatement of the Digi International Inc. 2021 Omnibus Incentive Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 4 funds |
| DIGITALBRIDGE GROUP INC. | May 23, 2025 | To approve, on a non-binding, advisory basis, named executive officer compensation. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 6 funds |
| DIGITALOCEAN HOLDINGS INC. | June 9, 2025 | Election of Class I Director: Padmanabhan Srinivasan Director Elections |
Board | For | FOR 8 funds |
WITHHOLD 4 funds |
| DOUGLAS ELLIMAN INC. | June 25, 2025 | Advisory vote on executive compensation (the say-on-pay vote). Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| DRAFTKINGS INC. | May 19, 2025 | To consider an amendment to the DraftKings Employee Stock Purchase Plan. Compensation |
Board | For | AGAINST 9 funds |
FOR 6 funds |
| DXC TECHNOLOGY CO. | July 30, 2024 | Approval of an increase in the number of shares available under the DXC Technology Company 2017 Non-Employee Director Incentive Plan. Compensation |
Board | For | AGAINST 9 funds |
FOR 2 funds |
| DYNE THERAPEUTICS INC. | May 30, 2025 | To vote, on an advisory basis, to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| EASTERN CO. | April 30, 2025 | Nonbinding advisory vote to approve the compensation of the named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 5 funds |
| EDITAS MEDICINE INC. | May 29, 2025 | To adopt and approve an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of the Company's capital stock from 200,000,000 to 395,000,000 and the number of authorized shares of the Company's common stock from 195,000,000 to 390,000,000. Capital Structure |
Board | For | AGAINST 4 funds |
FOR 4 funds |
| EDITAS MEDICINE INC. | May 29, 2025 | To approve an amendment and restatement of the Company's 2015 Stock Incentive Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 4 funds |
| ELECTROCORE INC. | September 3, 2024 | Approval, by non-binding advisory vote, of the resolution approving named executive officer compensation. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| ENANTA PHARMACEUTICALS INC. | March 13, 2025 | To approve an amendment to our 2019 Equity Incentive Plan. Compensation |
Board | For | FOR 3 funds |
AGAINST 3 funds |
| ENDAVA PLC | December 12, 2024 | To approve the Directors' Remuneration Report contained in the 2024 Annual Report and Accounts. Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| ENDAVA PLC | December 12, 2024 | To re-elect Mr. M Thurston as a Director. Director Elections |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| ENDAVA PLC | December 12, 2024 | To re-elect Mr. T Smith as a Director. Director Elections |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| ENDAVA PLC | March 14, 2025 | To approve: (i) the form of share repurchase contracts (the "Share Repurchase Contracts"), copies of which are appended to this document, for the purchase by the Company of its Class A ordinary shares of pounds0.02 each (including Class A ordinary shares represented by American Depositary Shares), at such prices as may be agreed pursuant to the terms of a Share Repurchase Contract, and the Company be and is hereby authorised to enter into any Share Repurchase Contract negotiated and agreed with a Counterparty (as defined in (ii)); and (ii) the counterparties with whom the Company may enter into a Share Repurchase Contract, being the counterparties (or their subsidiaries, successors or affiliates from time to time) included in this document (the "Counterparties"), provided that unless previously renewed, varied, or revoked by the Company at a general meeting, this authority shall expire on the fifth anniversary of the General Meeting. Extraordinary Transactions |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| ENOVIX CORP. | June 12, 2025 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 5 funds |
| ENPHASE ENERGY INC. | May 14, 2025 | To approve an amendment and restatement of our 2021 Equity Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 4,000,000 shares. Compensation |
Board | For | FOR 13 funds |
AGAINST 7 funds |
| ENTERPRISE BANCORP INC. | April 3, 2025 | To approve, on a non-binding, advisory basis, the compensation payable to the named executive officers of Enterprise in connection with the merger (the "Enterprise compensation proposal"). Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 8 funds |
| EOS ENERGY ENTERPRISES INC | May 15, 2025 | Amendment to our Amended and Restated 2020 Equity Compensation Plan. Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| ESSENTIAL UTILITIES INC. | May 7, 2025 | To approve an advisory vote on the compensation paid to the Company's named executive officers for 2024. Say-on-Pay |
Board | For | FOR 15 funds |
AGAINST 8 funds |
| EVERSOURCE ENERGY | May 1, 2025 | Consider an advisory proposal approving the compensation of our Named Executive Officers. Say-on-Pay |
Board | For | FOR 16 funds |
AGAINST 12 funds |
| EXTREME NETWORKS INC. | November 14, 2024 | Approve an amendment and restatement of the Extreme Networks, Inc. 2013 Equity Incentive plan to, among other things, add 2,300,000 shares of our common stock to those reserved for issuance under the plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 3 funds |
| EYEPOINT PHARMACEUTICALS INC. | June 18, 2025 | To approve Amendment No. 2 to the EyePoint Pharmaceuticals, Inc. 2023 Long-Term Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 2,900,000 shares. Compensation |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| EYEPOINT PHARMACEUTICALS INC. | June 18, 2025 | To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 5 funds |
| FARMERS & MERCHANTS BANCORP INC. | April 14, 2025 | 2025 Long-Term Stock Incentive Plan: The Board of Directors has adopted and recommends to the shareholders approval and adoption of the Farmers & Merchants Bancorp, Inc. 2025 Long-Term Stock Incentive Plan to replace the 2015 Long-Term Stock Incentive Plan. Compensation |
Board | For | FOR 2 funds |
AGAINST 5 funds |
| FARO TECHNOLOGIES INC. | May 21, 2025 | Amendment to the FARO Technologies, Inc. 2022 Equity Incentive Plan to increase the number of shares reserved for issuance thereunder by 1,500,000. Compensation |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| FASTLY INC. | June 11, 2025 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 6 funds |
| FATE THERAPEUTICS INC. | May 29, 2025 | To approve the amendment and restatement of the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder. Compensation |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| FIBROGEN INC. | June 4, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| FIRST BANCSHARES INC. | October 22, 2024 | A proposal to approve, on an advisory (non-binding) basis, specified compensation that may become payable to the named executive officers of The First Bancshares, Inc. in connection with the merger. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 8 funds |
| FIRST FINANCIAL NORTHWEST INC. | July 19, 2024 | Approval, on an advisory (non-binding) basis, of the compensation that may be paid or become payable to certain executive officers of the Company in connection with the asset sale. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| FIRST FOUNDATION INC. | May 29, 2025 | To approve the First Foundation Inc. Amended and Restated 2024 Equity Incentive Plan. Compensation |
Board | For | FOR 3 funds |
AGAINST 4 funds |
| FIRST HORIZON CORP. | April 29, 2025 | Ratification of appointment of KPMG LLP as auditors. Audit-related |
Board | For | AGAINST 12 funds |
FOR 8 funds |
| FIRST WESTERN FINANCIAL INC. | June 4, 2025 | To approve the First Western Financial, Inc. Omnibus Incentive Plan, as amended and restated April 23, 2025. Compensation |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| FORWARD AIR CORP. | June 11, 2025 | To approve the Company's 2025 Omnibus Incentive Compensation Plan. Compensation |
Board | For | FOR 7 funds |
AGAINST 3 funds |
| FRANKLIN BSP REALTY TRUST INC. | May 28, 2025 | ADVISORY VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 5 funds |
| FUBOTV INC. | June 17, 2025 | Approval of an amendment to the Company's 2020 Equity Incentive Plan to, among other things, increase the number of shares of Common Stock available for issuance. Compensation |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| GAMBLING.COM GROUP LIMITED | May 14, 2025 | To appoint Fintan Costello as a Class I director of the Company. Director Elections |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| GARMIN LTD | June 6, 2025 | Re-election of Min H. Kao as Executive Chairman Corporate Governance |
Board | For | AGAINST 12 funds |
FOR 5 funds |
| GLOBAL NET LEASE INC. | May 22, 2025 | Approval of the 2025 Omnibus Incentive Compensation Plan. Compensation |
Board | For | FOR 9 funds |
AGAINST 3 funds |
| GLOBANT S.A. | April 30, 2025 | Re-appointment of Ms. Andrea Mayumi Petroni Merhy as member of the Board of Directors for a term ending on the date of the Annual General Meeting of Shareholders of the Company to be held in 2028. Director Elections |
Board | For | AGAINST 6 funds |
FOR 3 funds |
| GOLAR LNG LIMITED | May 20, 2025 | To re-elect Daniel W. Rabun as a Director of the Company. Director Elections |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| GOLDEN ENTERTAINMENT INC. | May 22, 2025 | To approve the amendment and restatement of the Golden Entertainment, Inc. 2015 Incentive Award Plan. Compensation |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| GRAIL INC. | May 29, 2025 | Election of Class I Director to serve until the 2028 Annual Meeting of Stockholders, and until their respective successor has been duly elected and qualified: William (Bill) Chase Director Elections |
Board | For | WITHHOLD 6 funds |
FOR 1 fund |
| GRAY MEDIA INC. | May 7, 2025 | The approval of the amendment and restatement of the Gray Media, Inc. 2022 Equity and Incentive Compensation Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 4 funds |
| GREENWICH LIFESCIENCES INC. | December 19, 2024 | Proposal to approve an amendment to the Greenwich Life Sciences, Inc. 2019 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance under such plan to 4,000,000 shares from 1,500,000 shares. Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| HARLEY-DAVIDSON INC. | May 14, 2025 | COMPANY NOMINEE OPPOSED BY H PARTNERS: Jochen Zeitz Director Elections |
Board | Contested | FOR 11 funds |
WITHHOLD 1 fund |
| HARLEY-DAVIDSON INC. | May 14, 2025 | COMPANY NOMINEE OPPOSED BY H PARTNERS: Norman Thomas Linebarger Director Elections |
Board | Contested | FOR 11 funds |
WITHHOLD 1 fund |
| HERITAGE INSURANCE HOLDINGS INC. | June 10, 2025 | Approve an amendment to the Company's 2023 Omnibus Incentive Plan to increase the number of authorized shares by 1,800,000 shares Compensation |
Board | For | AGAINST 2 funds |
FOR 4 funds |
| HUDSON PACIFIC PROPERTIES INC. | May 14, 2025 | The approval of the Amended and Restated 2010 Incentive Award Plan. Compensation |
Board | For | FOR 9 funds |
AGAINST 3 funds |
| ICHOR HOLDINGS LTD. | May 14, 2025 | To approve the adoption of the Ichor Holdings, Ltd. 2025 Omnibus Incentive Plan. Compensation |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| IDEAYA BIOSCIENCES INC. | June 24, 2025 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 6 funds |
| INCYTE CORP. | June 10, 2025 | Approve amendments of the Company's Amended and Restated 2010 Stock Incentive Plan. Compensation |
Board | For | FOR 15 funds |
AGAINST 7 funds |
| INDIE SEMICONDUCTOR INC. | June 4, 2025 | To approve an amendment to the 2021 Omnibus Equity Incentive Plan to increase the number of shares of Class A Common Stock reserved for issuance thereunder by 17,000,000 shares. Compensation |
Board | For | FOR 4 funds |
AGAINST 4 funds |
| INFORMATIC | June 18, 2025 | Advisory vote on the compensation of our named executive officers. Say-on-Pay |
Board | Not determined | FOR 9 funds |
AGAINST 4 funds |
| INMODE LTD. | May 15, 2025 | To re-elect Dr.Michael Kreindel to serve as a Class III director of the Company, and to hold office until the annual general meeting of shareholders to be held in 2028 and until his successor is duly elected and qualified, or until his earlier resignation or retirement. Director Elections |
Board | For | AGAINST 3 funds |
FOR 2 funds |
| INMUNE BIO INC. | June 10, 2025 | To approve the Second Amended and Restated INmune Bio Inc. 2021 Stock Incentive Plan. Compensation |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| INNOVATIVE INDUSTRIAL PROPERTIES INC. | June 11, 2025 | Approval on a non-binding advisory basis of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 12 funds |
AGAINST 5 funds |
| INNOVEX INTERNATIONAL INC. | May 14, 2025 | To adopt the Company's 2025 Long-Term Incentive Plan. Compensation |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| INOGEN INC. | May 14, 2025 | To approve the Inogen, Inc. Amended and Restated 2023 Equity Incentive Plan. Compensation |
Board | For | AGAINST 2 funds |
FOR 4 funds |
| INSEEGO CORP. | September 23, 2024 | Election of Director to serve until the 2027 Annual Meeting of Stockholders: Christopher Harland Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| INSTIL BIO, INC. | May 28, 2025 | Election of Class I Director to hold office until the 2028 Annual Meeting of Stockholders: Bronson Crouch Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| INTERPUBLIC GROUP OF COMPANIES INC. | March 18, 2025 | IPG Compensation Proposal. Proposal to approve, on a non-binding, advisory basis, certain compensation that may be paid or become payable to IPG's named executive officers that is based on or otherwise relates to the merger; and Say-on-Pay |
Board | For | FOR 17 funds |
AGAINST 3 funds |
| INTUITIVE SURGICAL INC. | May 1, 2025 | The amendment and restatement of the Amended and Restated 2010 Incentive Award Plan. Compensation |
Board | For | AGAINST 15 funds |
FOR 12 funds |
| ITERIS INC. | October 22, 2024 | To approve, on a non binding, advisory basis, certain compensation that will or may become payable to Iteris, Inc.'s named executive officers in connection with the transactions contemplated by the Merger Agreement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 5 funds |
| JABIL INC. | January 23, 2025 | Approve (on an advisory basis) Jabil's executive compensation. Say-on-Pay |
Board | For | FOR 17 funds |
AGAINST 9 funds |
| JELD-WEN HOLDING INC. | April 24, 2025 | To approve the amended and restated 2017 Omnibus Equity Plan. Compensation |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| KE HOLDINGS INC | June 27, 2025 | As an ordinary resolution, to re-appoint PricewaterhouseCoopers and PricewaterhouseCoopers Zhong Tian LLP as auditors of the Company to hold office until the conclusion of the next annual general meeting of the Company and to authorize the Board to fix their remuneration for the year ending December 31, 2025. Audit-related |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| KE HOLDINGS INC | June 27, 2025 | As an ordinary resolution, to re-elect Mr. Jeffrey Zhaohui Li as a non-executive Director. Director Elections |
Board | For | AGAINST 4 funds |
FOR 3 funds |
| KE HOLDINGS INC | June 27, 2025 | As an ordinary resolution, to re-elect Ms. Xiaohong Chen as an independent non-executive Director. Director Elections |
Board | For | AGAINST 4 funds |
FOR 3 funds |
| KENNEDY-WILSON HOLDINGS INC. | June 5, 2025 | To approve an amendment to the Company's Second Amended and Restated 2009 Equity Participation Plan to increase the number of shares of the Company's common stock that may be issued thereunder by an additional 3,400,000 shares. Compensation |
Board | For | FOR 8 funds |
AGAINST 4 funds |
| KOHL'S CORP. | May 14, 2025 | To approve, by an advisory vote, the compensation of our Named Executive Officers. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 5 funds |
| KOPPERS HOLDINGS INC. | May 8, 2025 | PROPOSAL TO APPROVE OUR AMENDED AND RESTATED 2020 LONG TERM INCENTIVE PLAN Compensation |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| KRONOS WORLDWIDE INC. | May 14, 2025 | Nonbinding advisory vote approving named executive officer compensation. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 6 funds |
← Previous Page 2 of 8 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.